Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.
포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.
터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
Regulatory News: Genomic Vision (Paris:GV) (FR0011799907 – GV, la « Société »), une société de biotechnologie cotée sur Euronext développant des...
Regulatory News: Genomic Vision (FR0011799907 – GV, éligible PEA-PME) (Paris:GV), société de biotechnologie cotée sur Euronext développant des...
FiberSmart® is Genomic Vision’s Artificial Intelligence (AI) powered and fully integrated software automating genomic analysis FiberSmart®...
Genomic Vision et le CNRS lancent un programme d’oncologie avec le Centre de Recherche sur le Cancer de Marseille afin de développer des tests...
Déclaration au titre de l’article 223-16 du règlement général de l’Autorité des marchés financiers Regulatory News: Genomic Vision (Paris:GV) :...
Regulatory News: Genomic Vision (FR0011799907 - GV, la « Société ») (Paris:GV), société de biotechnologie cotée sur Euronext qui développe des...
Revenue from sales at end-September up 23.8% Revenue from activity for the first nine months of 2022 up 18.6% Cash position of €0.5 million at...
Regulatory News: GENOMIC VISION (FR0011799907 – GV – the “Company”) (Paris:GV), a biotechnology company that develops tools and services...
H1 2022 revenue from sales growth of 9.4% to €511k Current operating loss at €2.5 million Cash position of €1 million as of June 30, 2022...
귀하가 조회한 주식이 이 박스에 나타나며 쉽게 최근 시세로 돌아갈 수 있습니다.
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관